[Federal Register Volume 91, Number 68 (Thursday, April 9, 2026)]
[Notices]
[Pages 18008-18009]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-06807]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on April 20-21, 2026. A sample of agenda items to be discussed
include: a review of recent medical events; recommendations and advice
to support the NRC implementation of the ADVANCE Act; recommendations
on the staff's memo for licensing the use of alpha nuclides in
radiopharmaceutical therapy; recommendations on the potential
applications of artificial intelligence (AI) and deep learning
technologies to enhance the efficiency and effectiveness of the NRC
medical staff and the ACMUI; recommended best practices for the
preparation of reports, including guidance on writing subcommittee
reports and developing effective presentations, including Commission
presentations; assessment of ACMUI membership to determine if the ACMUI
would like to propose a change in membership to include an
interventional radiologist; ACMUI review and recommendations regarding
staff's proposed rulemaking on modernizing requirements relating to
physical protection of category 1 and category 2 quantities of
radioactive material rulemaking (topic is tentative based on its
rulemaking schedule); and NRC's medical radiation safety team updates.
FOR FURTHER INFORMATION CONTACT: Ms. A. Marra, email:
[email protected], telephone: 301-415-2509.
SUPPLEMENTARY INFORMATION: The agenda is subject to change. The current
agenda and any updates will be available on the ACMUI's Meetings and
[[Page 18009]]
Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/index.html or by emailing Ms. A. Marra at
the contact information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: April 20, 2026, from 9:00 a.m. to
5:00 p.m. and April 21, 2026, from 10:00 a.m. to 1:15 p.m. Eastern
Standard Time.
------------------------------------------------------------------------
Date Webinar information (Microsoft Teams)
------------------------------------------------------------------------
April 20, 2026............. Join: https://teams.microsoft.com/meet/27605721107301?p=NME89xbyHXSK32XAUI.
Meeting ID: 276 057 211 073 01.
Passcode: yF7DP3ri.
Call in number (audio only): +1 301-576-
2978,,558206708#.
Phone Conference ID: 558 206 708#.
------------------------------------------------------------------------
Public Participation: The meeting will be held as a webinar using
Microsoft Teams. Any member of the public who wishes to participate in
the meeting via Microsoft Teams or via phone should contact Ms. A.
Marra using the information below. Members of the public should also
monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates.
Conduct of the Meeting: The ACMUI Chair, Hossein Jadvar, M.D.,
Ph.D. will preside over the meeting. Dr. Jadvar will conduct the
meeting in a manner that will facilitate the orderly conduct of
business. The following procedures apply to public participation in the
meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. A. Marra using the contact information listed
above. All submittals must be received by the close of business on
April 13, 2026, and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public to the ACMUI
will be permitted during the meeting, at the discretion of the ACMUI
Chair.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2024.html on or about May 28, 2026.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. A. Marra of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 6th day of April, 2026.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-06807 Filed 4-8-26; 8:45 am]
BILLING CODE 7590-01-P